Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,817,863 papers from all fields of science
Search
Sign In
Create Free Account
XG 102
Known as:
XG-102
, XG102 peptide
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
D-JNKI-1
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Postoperative Ocular Inflammation: A Single Subconjunctival Injection of XG-102 Compared to Dexamethasone Drops in a Randomized Trial.
C. Chiquet
,
F. Aptel
,
+9 authors
F. Behar-Cohen
American journal of ophthalmology
2017
Corpus ID: 13309883
2015
2015
Subconjunctival injection of XG-102, a c-Jun N-terminal kinase inhibitor peptide, in the treatment of endotoxin-induced uveitis in rats.
I. El Zaoui
,
E. Touchard
,
+7 authors
F. Behar-Cohen
Journal of ocular pharmacology and therapeutics…
2015
Corpus ID: 25300977
PURPOSE XG-102, a TAT-coupled dextrogyre peptide inhibiting the c-Jun N-terminal kinase, was shown efficient in the treatment of…
Expand
2015
2015
Subconjunctival injection of XG-102, a JNK inhibitor peptide, in patients with intraocular inflammation: a safety and tolerability study.
BeydounTalal
,
DelocheCatherine
,
PerinoJulien
,
KirwanBridget-Anne
,
CombetteJean-Marc
,
Behar-CohenFrancine
2015
Corpus ID: 208177615
Abstract Purpose: We aimed to investigate the safety, tolerability, and systemic diffusion of a single escalating dose of XG-102…
Expand
2015
2015
Subconjunctival injection of XG-102, a JNK inhibitor peptide, in patients with intraocular inflammation: a safety and tolerability study.
Talal Beydoun
,
C. Deloche
,
Julien Perino
,
B. Kirwan
,
J. Combette
,
F. Behar-Cohen
Journal of ocular pharmacology and therapeutics…
2015
Corpus ID: 196301069
PURPOSE We aimed to investigate the safety, tolerability, and systemic diffusion of a single escalating dose of XG-102 (a 31-D…
Expand
2014
2014
XG-102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double-blind, placebo-controlled, dose-escalating study
C. Deloche
,
L. Lopez-Lazaro
,
S. Mouz
,
Julien Perino
,
C. Abadie
,
J. Combette
Pharmacology research & perspectives
2014
Corpus ID: 17484385
The aim of the study is to evaluate the safety, tolerability and pharmacokinetics (PK) of the JNK inhibitor XG‐102 in a…
Expand
2012
2012
The JNK Inhibitor XG-102 Protects against TNBS-Induced Colitis
K. Reinecke
,
S. Eminel
,
+10 authors
C. Sina
PloS one
2012
Corpus ID: 8442256
The c-Jun N-terminal kinase (JNK)-inhibiting peptide D-JNKI-1, syn. XG-102 was tested for its therapeutic potential in acute…
Expand
2010
2010
The c‐Jun N‐terminal kinase (JNK) inhibitor XG‐102 enhances the neuroprotection of hyperbaric oxygen after cerebral ischaemia in adult rats
J-R Liu
,
Y. Zhao
,
+7 authors
C. Eschenfelder
Neuropathology and applied neurobiology
2010
Corpus ID: 20973903
J‐R. Liu, Y. Zhao, A. Patzer, N. Staak, R. Boehm, G. Deuschl, J. Culman, C. Bonny, T. Herdegen and C. Eschenfelder (2010…
Expand
2010
2010
A peptide inhibitor of c-Jun N-terminal kinase for the treatment of endotoxin-induced uveitis.
E. Touchard
,
S. Omri
,
+9 authors
F. Behar-Cohen
Investigative ophthalmology & visual science
2010
Corpus ID: 45814848
PURPOSE To evaluate the effect of XG-102 (formerly D-JNKI1), a TAT-coupled dextrogyre peptide that selectively inhibits the c-Jun…
Expand
2010
2010
c-Jun N-Terminal Kinase Pathway Inhibition in Intracerebral Hemorrhage
D. Michel-Monigadon
,
C. Bonny
,
L. Hirt
Cerebrovascular Diseases
2010
Corpus ID: 5355655
Background: Inhibition of the c-Jun N-terminal kinase (JNK) pathway by the TAT-coupled peptide XG-102 (formerly D- JNKI1) induces…
Expand
Highly Cited
2008
Highly Cited
2008
The JNK Inhibitor XG-102 Protects from Ischemic Damage with Delayed Intravenous Administration Also in the Presence of Recombinant Tissue Plasminogen Activator
Karine Wiegler
,
C. Bonny
,
D. Coquoz
,
L. Hirt
Cerebrovascular Diseases
2008
Corpus ID: 21406784
Background: XG-102 (formerly D-JNKI1), a TAT-coupled dextrogyre peptide which selectively inhibits the c-Jun N-terminal kinase…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE